CEO Corner

  1. The Constant Search For More Efficient Paths To Approval 8/1/2016

    There are several general principles that can help accelerate clinical development, beginning and ending with a focus on getting the drug to the patients that need it.

  2. Biopharma Companies Are Focused On Access, Continued Innovation 7/1/2016

    Our shared goal should be to design an economically sustainable system that ensures patient access and promotes future innovation. Here are a few keys to consider as we work toward this goal.

  3. In A Political Year, We Need To Remember The Value Of Pharma/Bio 6/1/2016

    The drug pricing debate has been particularly challenging for our industry, and, with the presidential election coming up, I can’t help feeling that the attacks will only get worse.